Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It has not gone through the approval process that establishes safety and efficacy for a defined clinical use, and it should be understood as investigational and research-only
Inhibition of specific CYP enzymes involved in carcinogen activation inhibits the development of cancer in some animal models (55)
It also helps to control inflammation and bolster immune function
However, VEGF pathway activation in the context of normal tissue repair differs substantially from VEGF activity in established tumors
Urakaze, M., Kobashi, C., Satou, Y., Shigeta, K., Toshima, M., Takagi, M., Takahashi, J., & Nishida, H
US$ 26.47
US$ 26.27
US$ 21.88
US$ 21.40
